Cellectar Biosciences (CLRB) Capital Expenditures (2011 - 2024)
Cellectar Biosciences' Capital Expenditures was $5,880 in FY2025, down 94.4% from $104,195 in FY2024.
Analysis
Cellectar Biosciences (CLRB) Capital Expenditures (2011 - 2024) Analysis & Trends
From FY2010 onward, Cellectar Biosciences has reported Capital Expenditures for 16 years.
- Capital Expenditures shows a five-year compound annual growth rate of -37.6% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Capital Expenditures since FY2010.
- Per Business Quant data, Capital Expenditures in earlier years was $104,195 in FY2024 (-87.9%), $864,038 in FY2023 (+282.4%), $225,971 in FY2022 (+59.9%) and $141,361 in FY2021 (+126.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Cellectar Biosciences | 22.38 Mn | 22.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 61,286.00 |
| Jun 30, 2024 | 21,276.00 |
| Mar 31, 2024 | 21,633.00 |
| Dec 31, 2023 | 266,756.00 |
| Dec 31, 2022 | 117,856.00 |
| Sep 30, 2022 | 7,066.00 |
| Jun 30, 2022 | 70,979.00 |
| Mar 31, 2022 | 30,070.00 |
| Dec 31, 2021 | 129,739.00 |
| Sep 30, 2021 | 4,063.00 |
| Dec 31, 2020 | 17,210.00 |
| Jun 30, 2020 | 34,590.00 |
| Mar 31, 2020 | 10,553.00 |
| Dec 31, 2019 | 5,725.00 |
| Sep 30, 2019 | 3,093.00 |
| Jun 30, 2019 | 9,482.00 |
| Mar 31, 2019 | 6,242.00 |
| Dec 31, 2018 | 383,568.00 |
| Mar 31, 2018 | 1,425.00 |
| Sep 30, 2017 | 26,193.00 |
API Access
Cellectar Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();